Activating mutations in exon 19 of EGFR (delE746-A750) were unequivocally confirmed by PCR followed by FLA and by PNA–LNA PCR clamp techniques in three samples from CNS metastases and in a corresponding sample from a primary tumour. Here, EGFR is linked to neoplasm.